Himmelfarb Health Sciences Library, The George Washington University

Health Sciences Research Commons
Environmental and Occupational Health Faculty
Publications

Environmental and Occupational Health

1-1-2017

Clinical and Mucosal Immune Correlates of HIV-1
Semen Levels in Antiretroviral-Naive Men.
Brendan J W Osborne
Angie K Marsh
Sanja Huibner
Kamnoosh Shahabi
Cindy Liu
George Washington University
See next page for additional authors

Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/sphhs_enviro_facpubs
Part of the Environmental Public Health Commons, Occupational Health and Industrial Hygiene
Commons, Virology Commons, and the Virus Diseases Commons
APA Citation
Osborne, B., Marsh, A., Huibner, S., Shahabi, K., Liu, C., Contente, T., Nagelkerke, N., Kovacs, C., Benko, E., Price, L., MacDonald, K.,
& Kaul, R. (2017). Clinical and Mucosal Immune Correlates of HIV-1 Semen Levels in Antiretroviral-Naive Men.. Open Forum
Infectious Diseases, 4 (2). http://dx.doi.org/10.1093/ofid/ofx033

This Journal Article is brought to you for free and open access by the Environmental and Occupational Health at Health Sciences Research Commons.
It has been accepted for inclusion in Environmental and Occupational Health Faculty Publications by an authorized administrator of Health Sciences
Research Commons. For more information, please contact hsrc@gwu.edu.

Authors

Brendan J W Osborne, Angie K Marsh, Sanja Huibner, Kamnoosh Shahabi, Cindy Liu, Tania Contente, Nico J
D Nagelkerke, Colin Kovacs, Erika Benko, Lance Price, Kelly S MacDonald, and Rupert Kaul

This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/sphhs_enviro_facpubs/219

Open Forum Infectious Diseases
MAJOR ARTICLE

Clinical and Mucosal Immune Correlates of HIV-1 Semen
Levels in Antiretroviral-Naive Men
Brendan J. W. Osborne,1,2 Angie K. Marsh,1,2 Sanja Huibner,1,2 Kamnoosh Shahabi,1,2 Cindy Liu,6,7 Tania Contente,6 Nico J. D. Nagelkerke,5
Colin Kovacs,3 Erika Benko,3 Lance Price,6,7 Kelly S. MacDonald,1,2,4 and Rupert Kaul1,2
Departments of 1Medicine and 2Immunology, University of Toronto, Canada; 3Maple Leaf Medical Centre, Toronto, Canada; 4Department of Microbiology, Mount Sinai Hospital, Toronto, Canada;
5
Department of Community Medicine, United Arab Emirates University, AI Ain; 6Center for Microbiomics and Human Health, Division of Pathogen Genomics, Translational Genomics Research
Institute, Flagstaff, Arizona; 7Department of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University

Background. This study was done to characterize parameters associated with semen human immunodeficiency virus (HIV)-1
ribonucleic acid (RNA) viral load (VL) variability in HIV-infected, therapy-naive men.
Methods. Paired blood and semen samples were collected from 30 HIV-infected, therapy-naive men who have sex with men,
and 13 participants were observed longitudinally for up to 1 year. Human immunodeficiency virus RNA, bacterial load by 16S RNA,
herpesvirus (Epstein-Barr virus and cytomegalovirus [CMV]) shedding, and semen cytokines/chemokines were quantified, and
semen T-cell subsets were assessed by multiparameter flow cytometry.
Results. Semen HIV RNA was detected at 93% of visits, with >50% of men shedding high levels of virus (defined as >5000
copies/mL). In the baseline cross-sectional analysis, an increased semen HIV VL correlated with local CMV reactivation, the semen
bacterial load, and semen inflammatory cytokines, particularly interleukin (IL)-8. T cells in semen were more activated than blood,
and there was an increased frequency of Th17 cells and γδ-T-cells. Subsequent prospective analysis demonstrated striking interindividual variability in HIV and CMV shedding patterns, and only semen IL-8 levels and the blood VL were independently associated
with semen HIV levels.
Conclusions. Several clinical and immune parameters were associated with increased HIV semen levels in antiretroviral therapy-naive men, with induction of local proinflammatory cytokines potentially acting as a common pathway.
Keywords. cytokines; herpesviruses; HIV; microbiome; semen.

Semen containing human immunodeficiency virus (HIV)-1 is
the major vector worldwide for transmission from an HIVinfected, antiretroviral therapy (ART)-naive man to his sexual
partner(s). Although the blood HIV ribonucleic acid (RNA)
level is perhaps the best-defined predictor of transmission,
with the annual transmission risk in HIV serodiscordant
couples increasing from 0 to 25% as blood viral load (bVL)
increases from undetectable levels to >50 000 HIV-1 RNA
copies/mL [1], this reflects in part the correlation between
bVL and semen VL (sVL) [2]. In keeping with this, the sVL of
a male partner was an even stronger independent predictor of
HIV transmission than the bVL, with each log10 sVL increase
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being associated with a 1.8-fold increased HIV transmission
risk [2].
There can be substantial variability in the sVL, independent of the bVL, and at any given time they are moderately correlated at best [3]. Genital infections are an important cause
of this variability, with acute Neisseria gonorrhoeae urethritis
increasing the sVL almost 10-fold without any effect on bVL
[4]. However, approximately one third of ART-naive men
demonstrate levels of HIV RNA in semen that are disproportionately higher than those in blood, even in the absence of
symptomatic urethritis or asymptomatic classic sexually transmitted infections (STIs) [8]. Compartmentalized reactivation
of asymptomatic, persistent human herpesviruses (HHVs),
such as CMV and Epstein-Barr virus (EBV), have been linked
with an elevated sVL [5–9], and the association of a disproportionately high sVL with increased unprotected insertive
(but not receptive) sex suggests that nonclassic STI may also
be involved [10]. Associations are also seen between the sVL of
ART-naive men and total semen bacterial levels (one aspect of
the semen microbiome) [11, 12], several semen proinflammatory cytokines [9, 13–15], and the presence of various immune
cell subsets [15–17].
Effective ART dramatically reduces both the sVL and the
probability of HIV transmission [18, 19]. However, many
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HIV-infected men in the world do not know their status
and/or do not have access to ART, and so understanding the
factors that cause variability in the sVL of ART-naive men
remains an important priority, and this may lead to novel
avenues for HIV prevention. Our goal in this study was to
perform a comprehensive assessment in ART-naive men who
have sex with men of several clinical and mucosal parameters that have previously been associated with HIV RNA
shedding, to define independent predictors of increased
HIV sVL, and to assess prospective patterns of HIV semen
shedding.
METHODS
Study Participants and Design

Men who have sex with men infected with HIV for ≥1 year
were recruited through the Maple Leaf Medical Clinic, Toronto
between 2011 and 2013. Participants were ART naive and were
screened for STIs at each study visit. All participants provided
paired blood and semen samples at a single time point, and a
subgroup of men who opted to defer ART provided monthly
semen and blood samples for up to 1 year. All participants
provided informed, written consent; ethical approval for this
study was obtained through the research ethics board of the
University of Toronto.
Sample Collection and Diagnostic Testing

Blood was collected into acid citrate dextran, and semen was
collected by masturbation directly into a sterile container containing 10 mL of Roswell Park Memorial Institute (RPMI)
medium with penicillin/streptomycin after 48 hours of abstinence [20]. Samples were processed within 2 hours of collection. Semen plasma (SP) was isolated by centrifugation at
850 × g for 10 minutes, and blood plasma (BP) was isolated after
Ficoll density gradient centrifugation at 500 × g for 25 minutes.
Blood plasma and SP HIV RNA VL were assayed using the
Abbott RealTime HIV-1 assay using an automated m2000 system (Abbott Molecular Diagnostics). Due to occasional spillage
of RPMI medium during semen collection and/or sample transport, correction for semen dilution assumed a semen volume of
2 mL, as previously validated [20]. The lower limit of detection
for bVL and sVL were 50 and 300 HIV RNA copies/mL, respectively. High-level semen shedding was defined as a VL >5000
HIV RNA copes/mL [1].
Real-Time Quantification of Semen Herpesvirus Levels

Viral load quantification of herpes simplex virus (HSV)-1,
HSV-2, HHV-3, EBV, CMV, HHV-7, and HHV-8 was performed by reverse transcription-polymerase chain reaction
(PCR) using the genesig quantitative PCR (qPCR) detection
kit (PrimerDesign Ltd); HHV-6 A-B was quantified using the
RealStar PCR kit (Altona Diagnostics) [21]. In brief, deoxyribonucleic acid (DNA) was extracted from 400 μL of SP using a
DNA mini extraction kit (QIAGEN, Inc., Valencia, CA). For the
2 • OFID • Osborne et al

genesig kits, extracted SP DNA (5 μL) containing the provided
internal control was combined with a PCR mix containing 10
μL 2×Precision MasterMix, 1 μL Primer/Probe mix, and 4 μL
RNAse/DNAse-free water. For the RealStar PCR kit, 10 μL of
extracted SP DNA was added to the mastermix containing 5 μL
of master-A, 15 μL of master-B, and 1 μL of the internal control.
All viruses were quantified using the Applied Biosystems 7900
HT Real-Time PCR system with the after reactions conditions:
95°C for 10 minutes followed by 50 cycles of 95°C for 10 seconds (genesig) or 15 minutes (RealStar) and 60°C for 1 minute.
Results were analyzed using the Sequence Detection System,
version 2.4 (Applied Biosystems). Lower limit of detection was
200 copies/mL.
Cytokine and Trappin-2/Elafin Levels in Semen Plasma

Cytokine levels in SP were measured using the Meso Scale
Discovery multiplex System (Gaithersburg, MD). Fourteen
cytokines/chemokines were measured (lower limit of quantification listed in parenthesis): interleukin (IL)-1α (3.6
pg/mL), IL-6 (3.6 pg/mL), IL-1β (3.6 pg/mL), IL-8 (1.8 pg/
mL), monocyte chemoattractant protein (MCP)-1 (1.8 pg/
mL), macrophage-derived chemokine ([MDC] 1.8 pg/mL),
monokine induced by interferon-γ ([MIG] 1.8 pg/mL), macrophage inflammatory protein (MIP)-1β (29.28 pg/mL),
MIP-3α (14.64 pg/mL), regulated on activation, normal T cells
expressed and secreted ([RANTES] 3.6 pg/mL), IL-10 (1.8 pg/
mL), IL-17 (3.6 pg/mL), interferon-inducible protein (IP)-10
(14.64), and tumor necrosis factor (TNF)-α (1.8 pg/mL). All
samples were run in duplicate according to the manufacturer’s
protocol. For cytokine levels below the lower limit of detection
of the assay, values were reported as the lower limit of quantification based on the standard curve. Commercially available Trappin-2/Elafin enzyme-linked immunosorbent assay
kits (Hycult Biotech) were used to measure SP levels of Elafin
according to manufacturer’s instructions. The levels of many
cytokines coassociate in semen, and so to reduce concerns
around multiple comparisons we calculated a semen inflammation (SI) score: this was based on prior work in the female
genital tract (FGT) [22], with slight modification to accommodate FGT-semen cytokine differences. Men who had 4 or
more of 9 inflammatory cytokines (TNF-α, IL-1α, IL-1β, IL-6,
IL-8, IL-17, MIP-3α, IL-1β, and MIP-1β) in the upper quartile
were defined as inflamed, and the total number of cytokines
in the upper quartile constituted an inflammation score (from
0 to 9).
Bacterial Load Quantification

For bacterial load quantification, 500 μL of thawed SP was lysed
using a combination of chemical and mechanical methods
and purified using AllPrep DNA/RNA Mini Kit (QIAGEN).
Deoxyribonucleic acid was eluted in 100 μL of buffer EB,
whereas RNA was eluted in 50 μL. Reverse transcription was
performed using qScript cDNA SuperMix according to the

manufacturer’s instructions (Quanta Biosciences, Gaithersburg,
MD). Using the DNA fraction, bacterial load was quantfied,
measured as bacterial 16S recombinant RNA (rRNA) gene
copy/mL of SP using a broad-coverage qPCR assay, described
previously [23].

Table 1.

Clinical Demographics of Study Participants
Cross-Sectional Cohort
(n = 30)

Parameter
Age

34 (range, 24–56)

Years infecteda

3 (IQR, 1–4)

T-Cell Populations in Blood and Semen

HSV-1

80% (24/30)

Mononuclear cells were stained for 30 minutes with fluorochrome-labeled monoclonal antibodies (CD3G-FITC, CD8PETR, CD195-PerCPCy5.5, CD69-PECy7, β7integrin-APC,
HLADR-APCH7, CD196-Pacific Blue, CD3-605NC, CD4650NC) and a viability dye (Invitrogen) followed by fixation
for 30 minutes in 1% paraformaldehyde and analyzed using BD
LSR-II (BD Systems).

HSV-2

33.3% (10/30)

HSV1+/HSV2+

26.7% (8/30)

HSV1−/HSV2−

13.3% (4/30)

CMV

100% (30/30)

Absolute CD4a

440 (190–860)

Absolute CD8a

905 (230–2690)

CD4/CD8 ratioa

0.56 (0.17–1.97)

Blood viral load (copies/mL)

30 544 (824–500 000)

Semen viral load (copies/mL)

5496 (300–208 152)

Statistical Analysis

Semen bacterial load (16s copies/mL)

Flow cytometry analysis was performed using FlowJo analytical software, version 9.4.11 (Tree Star). Non-parametric MannWhitney U and Wilcoxon signed-rank analysis were performed
using IBM SPSS Statistics, version 20 (IBM Corporation).
Backward stepwise linear regression analyses were performed
for multiple independent covariants using SPSS, with P < .05
as the threshold for significance. Count and/or concentration
variables were logarithmically transformed. For longitudinal
multivariate analysis, a mixed model (MM) analysis was used
to take into account multiple observations/measurements produced per individuals within the study. Variables associated
with the outcome variable on univariate analysis (P < .1) were
selected for the multivariable analysis.

Semen CMV viral load (copies/mL)

282 (200–266 761)

Semen EBV viral load (copies/mL)

200 (200–409 156)

RESULTS
Cross-Sectional Cohort Demographics and Viral Loads

Thirty HIV-infected, antiretroviral-naive men provided paired
blood and semen samples. All participants were infected with
HIV for at least 1 year (median, 3 years; range, 1–23 years).
Study participants had median absolute CD4 and CD8 T-cell
counts of 440 cells/mm3 (range, 190–860) and 905 cells/mm3
(range, 230–2690), respectively. The median bVL was 30 544
HIV-1 RNA copies/mL (range, 824 to >500 000 copies/mL),
and median sVL was 5496 HIV-1 RNA copies/mL (range, 300–
208 152 copies/mL). All study participants were CMV seropositive, 80% (24 of 30) HSV-1 seropositive, and 33.3% (10 of
30) HSV-2 seropositive. Clinical parameters are summarized in
Table 1.
Semen HIV RNA was detected in 93% (28 of 30) of participants, and 50% (15 of 30) met criteria for high-level semen
shedding with an sVL ≥5000 copies of HIV-1 RNA/mL.
Two individuals had asymptomatic urethral infection with
Chlamydia trachomatis: both had high-level semen shedding
and elevated semen cytokines and T-cell populations, and these
individuals were removed from subsequent analysis. In 10.7%
(3 of 28) of men, the sVL exceeded the paired bVL, meeting
predefined criteria for disproportionately high HIV-1 semen

379 252 (19 672–12 736 702)

Abbreviations: CMV, cytomegalovirus; EBV, Epstein-Barr virus; HSV, herpes simplex virus;
IQR, interquartile range.
a

Median values reported.

shedding. At baseline, there was a weak correlation between
blood and semen VL (r = 0.26; P = .160). Viral load data are
summarized in Table 1.
Semen Cytokines and the Semen Viral Load

Levels of 14 cytokine/chemokines (see Methods) and of Elafin/
Trappin-2 were assayed in SP (Table 2). Semen inflammation,
defined as ≥4 of 9 proinflammatory cytokines in the top quartile for that cytokine (see above), was present in 6 of 28 (21%)
participants, and it was strongly associated with HIV semen
shedding (median sVL 4.89 log10 HIV RNA copies/mL for men
Table 2.
Cytokine/
Protein
IL-1α
IL-8
MCP-1

Seminal Plasma Cytokine and Chemokine Levels
Median
(pg/mL)

Percent
Detectable (%)

139

100%

1451

100%

Range
(pg/mL)
12–1135
176–180 408

3378

100%

289–79 593

MDC

26 034

100%

2298–127 178

MIG

33 511

100%

2939–114 179

MIP-3α

1167

93%

30–3769

RANTES

373

100%

25–1935

IL-10

49

82%

15–188

IL-17

37

82%

15–190

IL-1β

47

64%

24–592

IL-6
IP-10
MIP-1β
TNF-α
Trappin-2

119

100%

14–3866

35 768

100%

4019–222 383

251

68%

90–7216

82%

1.8–96

8.9
1871

100%

839–7823

Abbreviations: IL, interleukin; IP, interferon-gamma-induced protein; MCP, monocyte chemoattractant protein; MDC, macrophage-derived chemokine; MIG, monokine induced by
interferon-γ; MIP, macrophage inflammatory protein; RANTES, regulated on activation, normal T cells expressed and secreted; TNF, tumor necrosis factor. Bolded percentage was to
show cytokine/chemokine levels that were not detected in 100% of participants.
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strongly correlated with the sVL (Spearman correlation coefficient P = .65; P < .001). Subsequent analysis demonstrated that
the sVL was positively associated with semen levels of IL-1α
(P = .009), IL-8 (P = .033), IL-1β (P = .005), IL-6 (P = .037), and
MIP-1β (P = .031). To determine the strongest cytokine correlates of sVL, a partial correlation analysis controlling for bVL
was performed. After controlling for bVL, semen levels of IL-8
(P = .002), IL-1α (P = .024), IL-1β (P = .011), IL-6 (P = .013),
and MIP-1β (P = .006) remained significantly correlated with
the sVL. The independent association(s) of these individual
cytokines with the sVL was then assessed in a stepwise multivariate linear regression model, with IL-8 (P < .001) emerging
as the strongest independent cytokine correlate of the sVL, followed by IL-1β (P = .03) (Figure 1). Trappin-2/Elafin was readily detectable in SP, but levels did not correlate with either the
sVL or semen cytokine/chemokine levels.

P = .008

6

P (corrected) = .002

The Semen Viral Load and Local Herpesvirus Reactivation

3.0

2.0

1.0

0.0
2.0

3.0

4.0

5.0

6.0

Log10 [semen HIV RNA/mL]

Log10 [semen IL1β] pg/mL

4.0

P (corrected) = .011

3.0

2.0

1.0

0.0
2.0

3.0

4.0

5.0

6.0

Log10 [semen HIV RNA/mL]
Figure 1. Association of semen human immunodeficiency virus (HIV) viral load
with local inflammation and proinflammatory cytokines. Levels of semen HIV RNA in
antiretroviral therapy-naive men were strongly associated with both the presence/
absence of semen inflammation (top panel), based on modification of a previously
defined mucosal algorithm, and with levels of individual proinflammatory cytokines
(bottom 2 panels; interleukin [IL]-8 and IL-1β shown).

with SI vs 3.42 without; MW P = .008) (Figure 1). Furthermore,
an inflammation score that was calculated as the number
of these cytokines in the top quartile (range, 0–9) was also
4 • OFID • Osborne et al

Herpesvirus qPCR was performed on all semen samples; 63%
(19 of 30) passed internal control standards for CMV and 67%
(20 of 30) for EBV. Internal control/run failure for the remaining samples may be due to the presence of PCR inhibitors, a
common issue with qPCR assays in SP [24]. Cytomegalovirus
was detected in the SP of 11 of 19 (58%), and EBV was detected
in 6 of 20 (30%) participants; median CMV and EBV VL were
486 copies CMV DNA/mL (range, 200–266 761) and 200 copies
EBV DNA/mL (range, 200–409 157), respectively. Semen HSV1, HSV-2, HHV-3, HHV-7, and HHV-8 were undetectable in
all patients, and HHV6 was only detected at very low levels in
the semen of 2 participants. Therefore, subsequent analysis was
focused on CMV and EBV.
Semen levels of CMV but not EBV correlated with the HIV
sVL (P = .014 and P = .511, respectively (Figure 2). Semen
CMV levels tended to be higher in men with SI (median 4.40
vs 2.38 log10 DNA copies/mL; MW P = .063) and were directly
correlated with the inflammation score (Spearman’s rho = 0.64;
P = .006), whereas EBV levels were not related with either the
presence or degree of inflammation. In particular, CMV levels
correlated with semen cytokines IL-10 (0.048), IL-1β (<0.001),
IL-6 (0.009), MIP-1β (0.004), and TNF-α (0.006). The independent association of these cytokines with semen CMV VL
was assessed in a stepwise multivariate linear regression model
with semen IL-1β level (P < .001) correlating most strongly with
CMV VL.
Semen T-Cell Immune Parameters and the Semen Viral Load

Semen mononuclear cells (SMCs) were analyzed by flow cytometry in the subset of men (13 of 30; 43.3%) who consented to be
observed longitudinally, to evaluate the prospective associations
of T-cell phenotype and activation status with sVL. Ninetythree semen samples (approximately 7 samples per participant)
were collected, and for practical reasons flow cytometry was
performed on 76 of these samples (82%): adequate semen T-cell
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Figure 2. Reactivation of semen herepesviruses and the semen HIV viral load. Semen HIV RNA levels in ARV-Naive men were associated with levels of (A) semen CMV
DNA (left) but not (B) semen EBV DNA (right).

Bacterial Load in Semen and the Semen Viral Load

To broadly assess whether the endogenous microbiome of the
semen compartment [25] impacted semen immunology and
sVL, total bacterial load was quantified by 16S rRNA. In men
free of bacterial STIs, the total bacterial load was positively correlated with both the HIV sVL (Spearman rho = 0.51; P = .016)
(Figure 3) and the SI score (Spearman rho = 0.48; P = .024), and

it was higher in participants meeting criteria for SI (median
log10 bacterial load 7.03 vs 5.40; P = .003). Furthermore, the bacterial load was significantly correlated with semen levels of the
individual cytokines IL-8 (P = .004), MCP-1 (P = .022), MDC
(P = .017), MIP-3α (P = .008), IL-6 (P = .012), IP-10 (P = .007),
and TNF-α (0.046). However, no association of the bacterial
load was observed with baseline clinical parameters or the local
reactivation of CMV or EBV.
Longitudinal Cohort Demographics

A subgroup of participants (n = 13) provided monthly, paired
semen and blood samples for up to 12 months, or until initiation of ART, to permit assessment of sVL and semen immunology changes within an individual. Herpes simplex virus-1

6

Semen HIV-1 Viral Load
Log10 Copies/mL

numbers (above our cutoff of ≥50 cell events) were present
for CD4+ T-cell analysis in 69 of 76 (91%) and for CD8+ T-cell
analysis in 73 of 76 (96%). Semen T cells were immunologically
much more activated than those in the blood of the same participant. In particular, coexpression of CD38 and HLA-DR was
higher on both semen CD4+ T cells (median, 16.25% vs 0.89%;
P < .001) and CD8+ T cells (median, 13.75% vs 3.91%; P = .039),
as was the early activation/TRM marker CD69 on both CD4+
(32.80% vs 3.14%; P < .001) and CD8+ (57.0 vs 5.17; P < .001)
T cells. Semen CD4+ T cells also expressed higher levels of the
HIV coreceptor CCR5 (24.15% vs 4.3%; P < .001) and of the
Th17 marker CCR6 (28.8 vs 4.3; P = .003), whereas expression
of β7, a proxy for the mucosal homing integrin α4β7+, was lower
on semen CD4+ T cells (0.9% vs 2.1%; P = .013). The proportion
of CD3+ T cells expressing the gamma-delta receptor (CD3G)
tended to be higher in peripheral blood mononuclear cells than
SMCs (2.84 vs 0.94; P = .180), although semen CD3G+ T cells
expressed higher levels of CCR6 (83.7 vs 0.43; P < .001).
Overall, CD4+ and CD8+ T-cell numbers in the semen
were strongly correlated with a number of immune and virologic semen parameters, including the CMV VL (Spearman
rho = 0.78 and 0.89, both P < .01) and the SI score (Spearman
rho = 0.77 and 0.85, both P < .001), and less strongly with the
semen HIV VL (Spearman rho = 0.48 and 0.64, P = .11 and
P = .02, respectively). No T-cell associations were seen with
semen levels of EBV or with the semen bacterial load (see
below).

P = .013
R2 = 0.27

5

4

3

2

4

5

6

7

8

Semen 16S rRNA Bacterial Load
Log10 Copies/mL
Figure 3. Association of 16s rRNA bacterial load with semen HIV-1 RNA levels. The total concentration of bacterial 16s rRNA, a crude marker of the semen
microbiome, was positively correlated with semen HIV RNA levels in antiretroviral
therapy-naive men.
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Longitudinal Correlates of Human Immunodeficiency Virus Shedding
in Semen

Semen parameters that had been associated with the sVL in the
cross-sectional analysis also varied over time. Cytomegalovirus
reactivation was more common than EBV in semen, with detection in 9 of 13 vs 4 of 13 participants at any time point, and at
29.0% (27 of 93) vs 7.5% (7 of 93) of total study visits, respectively. The median semen CMV VL was 241 copies/mL (range,
200–266 761 copies/mL) and exceeded 5000 copies/mL during 29.6% (8 of 27) reactivations; the median semen EBV VL
was also 200 copies/mL (range, 200–353 125 copies/mL) and
exceeded 5000 copies/mL during 28.6% (2 of 7) reactivations.
Semen flow cytometry assays were performed for 76 of 93 samples collected, and sufficient (>50 cells per sample) semen CD4+
T cells for analysis were present in 69 of 76 (90.1%) samples and
CD8+ T cells in 73 of 76 (96.1%) samples. In general, the semen
bacterial load, semen cytokine levels, and T-cell parameters
were relatively stable over time (data not shown).
Finally, a multivariable MM that incorporated the longitudinal viral, immune, and bacterial load data was then used to

6 • OFID • Osborne et al
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High-level semen shedding (>5000 copies/mL) had been
detected at enrollment in 45.5% (5 of 11) of the STI-free prospective participants: during follow up, high-level shedding was
detected at 1 study visit or more in 69% (9 of 13) and overall at
51.6% (48 of 93) of study visits. The median sVL was 0.95 log10
(0.79-fold) lower than the bVL (median bVL 4.45 log10 copies/
mL, range 2.92–5.18 log10 copies/mL vs median sVL 3.50 log10
copies/mL, range 2.48–5.00 log10 copies/mL), but there was substantial inter-individual variability. In approximately half of the
participants, the sVL was consistently lower than the blood (6 of
13 participants; representative example) (Figure 4A). Although
only 23% (3 of 13) of study men had an undetectable sVL at
any time point, 1 individual maintained an undetectable sVL at
each of 9 study visits despite a median bVL of 3.69 log10 copies/
mL (range, 3.06–3.87 log10 copies/mL) (Figure 4B). One participant (1 of 13) consistently demonstrated a disproportionately
high sVL (Figure 4C), whereas in the remaining 6 of 13 participants, the sVL was sometimes lower than blood and sometimes
disproportionately high (Figure 4D). In addition, the variability
in semen versus blood HIV-1 RNA levels was assessed by calculating the ratio and variance of log10 semen/log10 blood RNA
levels (Table 3). Although the median semen/blood VL ratio
was 0.87, it exceeded 1 in 2 participants (15%), and there was
considerable heterogeneity in the variance of this ratio, ranging
from 0.002 to 0.149.

C

HIV viral load
(log10 HIV RNA copies/mL)

Patterns and Correlates of Human Immunodeficiency Virus Shedding
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and HSV-2 seroprevalence was 92% (12 of 13) and 46% (6 of
13), respectively, and the median duration of follow-up was
7 months (range, 2–12 months) with a total of 93 sample visits
(an average of just over 7 visits per participant).
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Figure 4. Longitudinal patterns of HIV RNA semen shedding over time in antiretroviral therapy-naive men. Examples of semen HIV RNA semen shedding patterns
over time: (a) blood viral load (VL) consistently higher than semen; (b) persistently
undetectable semen HIV RNA VL; (c) sustained disproportionate HIV semen shedding; (d) intermittent disproportionate HIV semen shedding. blood plasma; semen
plasma.

Table 3.

Prospective Variability in the Semen/Blood HIV RNA Viral Load Ratio
Log10 sVL/Log10 bVLa

No. of Visits

Variance

Minimum

Maximum

001

0.903

8

0.005

0.80

1.02

002

1.373

7

0.017

1.25

1.64

003

1.130

9

0.149

0.87

2.19

004

0.772

9

0.002

0.68

0.80

005

0.797

5

0.010

0.66

0.90

006

0.943

10

0.011

0.73

1.03

007

0.970

2

0.046

0.82

1.12

008

0.940

10

0.012

0.82

1.13

009

0.671

7

0.054

0.53

1.16

010

0.671

9

0.002

0.64

0.81

011

0.887

2

0.002

0.85

0.92

012

0.824

7

0.033

0.69

1.20

013

0.873

8

0.013

0.62

0.97

All visits

0.873

93

0.062

0.53

2.19

Patient ID

Abbreviations: bVL, blood viral load; HIV, human immunodeficiency virus; ID, identification; RNA, ribonucleic acid; sVL, semen viral load.
a

Median values reported

assess independent associations of the HIV sVL (see Methods).
In this prospective analysis, the only independent associations
of HIV sVL were the bVL (P < .001) and semen levels of the
proinflammatory chemokine IL-8 (P < .001). For every log10
unit increase in bVL, the sVL increased by 0.40 log10, and for
every log10 increase in the IL-8, the sVL increased by 0.75 log10.
In this prospective analysis, the semen to blood HIV VL ratio,
which was calculated to assess the contribution of individual
semen parameters to the local HIV VL, was most strongly associated with semen IL-8 levels (P < .001) (Figure 5).
DISCUSSION

The semen of an HIV-infected, ART-naive man is the vector for
most global HIV transmission, with the HIV RNA VL in both
blood and semen being independent predictors of HIV transmission risk [2]. Although the semen HIV RNA VL is generally
lower than that in blood, virus levels in the semen compartment are more variable [26–28], and a subset of men manifest
disproportionately high levels of HIV in semen [8, 10, 29] with
an increased sVL linked to STIs, herpesvirus reactivation, and
local immune activation [4–6, 30]. Prior studies have often
been cross-sectional and focused on individual semen parameters, and it is not clear whether patterns of differential HIV
shedding are stable in an individual over time. Therefore, the
current study prospectively assessed the association of multiple
semen parameters with the sVL in ART-naive men, to define
independent associations. Factors associated with the HIV
RNA sVL in univariate analysis included the blood VL, semen
CMV reactivation, levels of proinflammatory cytokines and
chemokines, the total bacterial load, and semen T-cell numbers.
However, there was substantial inter-individual and intra-individual variability in the patterns of HIV semen shedding over
time, and the only independent associations of semen HIV

RNA levels were the bVL and semen levels of the proinflammatory chemokine IL-8, suggesting that the latter may constitute an inflammatory biomarker that links heterogeneous local
causes of increased HIV RNA shedding in semen.
Interleukin-8 is a proinflammatory cytokine produced by
a variety of cells, particularly macrophages/monocytes [31].
Macrophages constitute 20%–30% of white blood cells in semen,
and they are almost 10-fold more common than T-lymphocytes
(2%–5%) [32]. Not only are increased semen levels of IL-8 seen
in the context of HIV infection, but IL-8 also increases HIV
replication in cervical explant tissue models, and competitive
inhibition of the IL-8 receptor CXCR2 decreases explant HIV
susceptibility by 45%–70% [33]. Although our study demonstrates that IL-8 is an important local correlate of semen HIV
levels, it is not known whether the relationship is causal or
whether IL-8 serves as a biomarker for an additional, unmeasured factor associated with SI. Future studies should confirm
the cellular origin of IL-8 and assess the ability of therapeutic
strategies targeting IL-8 to reduce semen HIV levels.
Although several of the “upstream” mucosal parameters
associated with the sVL had been previously described, others were novel. Local reactivation of CMV has been previously associated with the sVL [9, 30], and increased semen
cytokines have been associated with semen levels of both
CMV and HIV [8, 34, 35]. The absolute number of HIVspecific T cells in semen has also been associated with the
sVL [8], although this was not seen in studies where a substantial proportion of men were on ART [34]. However,
the novel finding of an association between the total semen
bacterial load and the sVL in the absence of classic STIs
strongly suggests that the semen microbiome plays a role in
HIV transmission, an area for future research. The fact that
local CMV reactivation, the semen bacterial load, and semen
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Figure 5. Association of semen interleukin (IL)-8 level with the relative abundance of HIV RNA in semen versus blood. Semen levels of the proinflammatory
cytokine IL-8 were strongly correlated with relative increases in semen versus blood
HIV RNA in antiretroviral therapy-naive men (random intercept linear mixed model).

T-cell numbers were all associated with semen proinflammatory cytokines, and that semen IL-8 levels were the only local
(semen) parameter independently associated with the sVL on
multivariate analysis, suggests that IL-8 might serve as a final
common pathway for an increased sVL.
There was considerable inter-individual heterogeneity in
patterns of semen HIV shedding. The sVL has generally been
observed to be significantly lower than the bVL [36, 37], and,
on average, that was also the case in our study. However, we
found that less than half of all participants consistently had
an sVL lower than the bVL, whereas a slight majority (>53%)
either consistently or intermittently demonstrated a disproportionately high sVL. This variability has implications for predicting HIV transmission at an individual level, and it stresses the
importance of prospective studies. However, it is important to
note that the early initiation of ART is now the norm in developed countries [38], both for the health benefits provided to
the HIV-infected person and to reduce HIV transmission. The
impact of effective ART on the sVL will supercede the parameters that we studied, because ART rapidly reduces the sVL
to undetectable levels in most men [19, 27, 39–41]. However,
because many people infected by HIV globally are unable to
access therapy, it is still important to study HIV semen shedding in ART-naive men.
The sample size was limited in the current study, particularly for the prospective analysis of semen shedding, in large
part because ART is now recommended for all HIV-infected
men. Despite this, our prospective analysis of the relationship
between the sVL and multiple semen parameters provides
new insights of public health importance. In particular, the
8 • OFID • Osborne et al

prospective cohort component clearly confirmed the bVL to
be a strong predictor of semen HIV levels, as has been previously described, while adding semen IL-8 levels as a strong,
independent mucosal (compartmentalized) predictor. Semen
VLs were calculated based on an assumed volume of 2 mL,
due to relatively frequent spillage of collection medium during
sample collection and transport. Because there is inter-individual heterogeneity in semen volume, this will have led to some
imprecision in our calculation of sVL and semen cytokine concentrations, but in prior studies this assumption did not affect
the outcome of analyses based on these parameters [12, 20].
Mixed models and generalized estimating equations (GEE)
are both statistical approaches to deal with correlated observations; GEE deals with marginal (ie, population level) models,
and MM deals with conditional models. These approaches may
provide slightly different results in nonlinear models, but for
linear models (such as were used in this analysis), the 2 methods/models are practically identical for the random intercept
models, and MM was used in this case to enable multilevel,
random slope models.
CONCLUSIONS

In summary, our study confirms considerable variability in
the sVL among HIV-infected, ART-naive men, and patterns of
shedding vary considerably over time. Fluctuation in the sVL
is not only dependent on the bVL, but it is also associated with
multiple compartmentalized factors in semen, including T-cell
influx, herpesvirus reactivation, and the microbiome, with
effects on the sVL mediated through increased local levels of
proinflammatory cytokines, particularly IL-8.
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